Important aspects of plasmid DNA purity are explained in the new article "Assessing pDNA Purity For Cell & Gene Therapies" by our senior analytical consultant Brian Glass. The application of conventional development methods to the difficulties encountered in producing gene therapy products is examined in this article. Brian highlights the upcoming USP 1040 chapter and offers advice on developing successful control measures for plasmid DNA, a crucial building block in the industry. https://hubs.ly/Q02zMqzM0
Pharmatech Associates, a USP company’s Post
More Relevant Posts
-
Learn about the intricacies of manufacturing in the cell and gene therapy space in this article in SupplyChainBrain written by my colleagues Dr Paolo Siciliano, Martin Sowden, Shanton Wilcox, and Harry Ustik. They break it down into 5 key areas of opportunity for manufacturers in this space. #AutologousCommercialCellTherapy #GeneTherapy #MedicalManufacturingChallenges
Five key manufacturing challenges in autologous commercial cell and gene therapies
paconsulting.smh.re
To view or add a comment, sign in
-
Gain insights on our take on how we solve three main challenges in advancing cell and gene therapies to clinic. Join Qian(Sarah) Li, PhD, EMBA to learn about how #plasmid DNA serves essential roles as critical materials for cell and gene therapy applications and various key considerations including emerging methods for yield improvement, characterization and quality control. #celltherapy #genetherapy
To view or add a comment, sign in
-
Learn about today’s top challenges in cell and gene therapy and how to solve them from Ahmed Youssef at this year’s ESACT. Explore more about Sartorius cell and gene therapy solutions: https://sar.to/nsk5p #SimplifyingProgress #InThisTogether #AdvancedTherapies #CellandGeneTherapy #ESACT #ESACT2024
To view or add a comment, sign in
-
Navigating the evolving landscape of approved cell and gene therapies poses a challenge for the drug development community. Discover insights on aligning expectations and implementing effective bioanalytical strategies in our latest eBook. For more in-depth knowledge, explore our new Cell and Gene Therapy Accelerating Science Feature: https://lnkd.in/ea6_b8_v #genetherapy, #celltherapy, and #drugdevelopment. #AAPS #BiotechInsights
Download Your Exclusive SelectScience How-to-Buy eBook
To view or add a comment, sign in
-
👉Interested to learn about the role of AAVs in gene therapy, how to manufacture AAVs, and moving from discovery to clinical and commercial manufacturing? Download our eBook to read about the considerations for your gene therapy manufacturing strategy!: https://lnkd.in/gxEPCqGE #genetherapy #AAVmanufacturing #clinicalmanufacturing #AAVs
Considerations for Your Gene Therapy Manufacturing Strategy | Thermo Fisher Scientific - US
thermofisher.com
To view or add a comment, sign in
-
The #conference year is slowly coming to an end. I think this is one of the last stops for Coriolis Pharma and a good opportunity to discuss with our #team. 🕚 If you are in #AAV, #Lentivirus and any other #viralvector #development and/or #characterization, make sure to get an appointment with Evelyn Eggenstein and Jörg Müller in Hashtag #Boston. 📞 If you are not in Boston, fine as well. Approach us directly via #LinkedIn 📧 or read more about viral vectors on our #homepage 🖥: https://lnkd.in/d_HhVPgm
Our colleagues Evelyn Eggenstein and Jörg Müller will be in #Boston at 5th Annual Gene Therapy Analytical Development Summit 2023. Meet them at booth #19 and learn how we can help you with our analytical services up to GMP. Also, don't miss the presentation of our scientific advisor Prof. Dr. Gideon Kersten on "Latest analytical methods for characterization of viral particles in cell and gene therapy products". See you soon! #CoriolisPharma #formulatinginnovation #analyticalservice #GTAD
To view or add a comment, sign in
-
-
👉Interested to learn about the role of AAVs in gene therapy, how to manufacture AAVs, and moving from discovery to clinical and commercial manufacturing? Download our eBook to read about the considerations for your gene therapy manufacturing strategy: https://lnkd.in/gxEPCqGE #genetherapy #AAVmanufacturing #clinicalmanufacturing #AAVs
Considerations for Your Gene Therapy Manufacturing Strategy | Thermo Fisher Scientific - US
thermofisher.com
To view or add a comment, sign in
-
Unlocking Complex Cell-based Gene Therapies Session 1 presentation by Carl June is starting now. "The Evolution of Cell and Gene Therapies: Current Advances and Challenges." https://lnkd.in/eiVwStgR #CGT
To view or add a comment, sign in
-